Drug Company Up 36%, FDA Accepts New Drug Application (SOMX)

Recent Articles by mary lou

Long Ideas

Company News

Short Ideas

Trading Ideas

PicksThatMove.com reports that the FDA has given Somaxon Pharmaceuticals Inc. (NASDAQ: SOMX) a new Prescription Drug User Fee Act date of December 4th for its drug Silenor. The FDA accepted the company’s resubmitted New Drug Application for Silenor, its drug to treat insomnia.

Somaxon, (SOMX) a pharmaceutical company, is surging in today’s trading session, posting a 36% gain today, up $1.08 to $4.08. The company’s stock has jumped 456% since June, according to the website.


There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.